Literature DB >> 7599044

Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore.

C Y Shi1, T W Phang, Y Lin, A Wee, B Li, H P Lee, C N Ong.   

Abstract

The present study characterised p53 mutations in 44 hepatocellular carcinomas (HCCs) from Chinese patients residing in a high-incidence area. Twelve point mutations (27%) were detected in tumour tissues using single-strand conformation polymorphism analysis followed by direct DNA sequencing. Remarkably, no mutations were observed at codon 249. This is in contrast to HCCs from other high HCC incidence areas with endemic aflatoxin exposures, in which codon 249 is a mutational hot spot. It is therefore suggested that risk factors other than dietary exposure to aflatoxin may contribute to the high HCC incidence in Singapore.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599044      PMCID: PMC2034128          DOI: 10.1038/bjc.1995.291

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Geographic variation of p53 mutational profile in nonmalignant human liver.

Authors:  F Aguilar; C C Harris; T Sun; M Hollstein; P Cerutti
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

2.  Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.

Authors:  C Challen; J Lunec; W Warren; J Collier; M F Bassendine
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

3.  Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.

Authors:  S Hosono; M J Chou; C S Lee; C Shih
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

4.  Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas.

Authors:  B Debuire; P Paterlini; P Pontisso; G Basso; E May
Journal:  Oncogene       Date:  1993-08       Impact factor: 9.867

5.  Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.

Authors:  N Nishida; Y Fukuda; H Kokuryu; J Toguchida; D W Yandell; M Ikenega; H Imura; K Ishizaki
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701

6.  Mutation of p53 gene in hepatocellular carcinoma in Taiwan.

Authors:  J C Sheu; G T Huang; P H Lee; J C Chung; H C Chou; M Y Lai; J T Wang; H S Lee; L N Shih; P M Yang
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

7.  Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells.

Authors:  D D Levy; J D Groopman; S E Lim; M M Seidman; K H Kraemer
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

8.  Aberrations of p53 gene in human hepatocellular carcinoma from China.

Authors:  D Li; Y Cao; L He; N J Wang; J R Gu
Journal:  Carcinogenesis       Date:  1993-02       Impact factor: 4.944

9.  p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China.

Authors:  K A Scorsone; Y Z Zhou; J S Butel; B L Slagle
Journal:  Cancer Res       Date:  1992-03-15       Impact factor: 12.701

10.  High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.

Authors:  P Coursaget; N Depril; M Chabaud; R Nandi; V Mayelo; P LeCann; B Yvonnet
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more
  3 in total

1.  Applications of new technology in molecular epidemiology and their relevance to occupational medicine.

Authors:  D Koh; A Seow; C N Ong
Journal:  Occup Environ Med       Date:  1999-11       Impact factor: 4.402

2.  The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas.

Authors:  H Sugo; S Takamori; K Kojima; T Beppu; S Futagawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.

Authors:  A Rashid; J S Wang; G S Qian; B X Lu; S R Hamilton; J D Groopman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.